Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
13 02 2019
Historique:
received: 18 01 2019
revised: 06 02 2019
accepted: 08 02 2019
entrez: 21 2 2019
pubmed: 20 2 2019
medline: 20 2 2019
Statut: epublish

Résumé

The regulation of oxygen (O₂) levels is crucial in embryogenesis and adult life, as O₂ controls a multitude of key cellular functions. Low oxygen levels (hypoxia) are relevant for tissue physiology as they are integral to adequate metabolism regulation and cell fate. Hence, the hypoxia response is of utmost importance for cell, organ and organism function and is dependent on the hypoxia-inducible factor (HIF) pathway. HIF pathway activity is strictly regulated by the family of oxygen-sensitive HIF prolyl hydroxylase domain (PHD) proteins. Physiologic hypoxia is a hallmark of the hematopoietic stem cell (HSC) niche in the bone marrow. This niche facilitates HSC quiescence and survival. The present review focuses on current knowledge and the many open questions regarding the impact of PHDs/HIFs and other proteins of the hypoxia pathway on the HSC niche and on normal and malignant hematopoiesis.

Identifiants

pubmed: 30781787
pii: cells8020155
doi: 10.3390/cells8020155
pmc: PMC6406588
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Cell Biol. 2010 Oct;12(10):1007-13
pubmed: 20852629
Cell Stem Cell. 2010 Sep 3;7(3):391-402
pubmed: 20804974
Nature. 2014 Apr 10;508(7495):269-73
pubmed: 24590072
J Med Chem. 2013 Dec 12;56(23):9369-402
pubmed: 23977883
Gynecol Oncol. 1998 Nov;71(2):270-7
pubmed: 9826471
Int J Hematol. 2017 Jul;106(1):18-26
pubmed: 28540498
Cancer Cell. 2009 Jun 2;15(6):527-38
pubmed: 19477431
Mol Cell Biol. 2008 May;28(10):3386-400
pubmed: 18332118
Blood. 2015 Apr 23;125(17):2621-9
pubmed: 25762174
Immunity. 2016 Sep 20;45(3):597-609
pubmed: 27590115
J Clin Invest. 2017 Oct 2;127(10):3624-3639
pubmed: 28846069
Genes Dev. 2001 Oct 15;15(20):2675-86
pubmed: 11641274
J Biol Chem. 2015 Mar 13;290(11):7195-207
pubmed: 25635047
Nat Med. 2014 Nov;20(11):1315-20
pubmed: 25326802
Cell. 2017 May 18;169(5):807-823.e19
pubmed: 28479188
J Exp Med. 2015 Nov 16;212(12):2133-46
pubmed: 26552707
Nature. 2015 Oct 1;526(7571):126-30
pubmed: 26416744
High Alt Med Biol. 2012 Sep;13(3):162-8
pubmed: 22994515
Cell Stem Cell. 2010 Aug 6;7(2):150-61
pubmed: 20682444
Cell. 2005 Jul 1;121(7):1109-21
pubmed: 15989959
Nature. 2010 Aug 12;466(7308):829-34
pubmed: 20703299
Cell Death Differ. 2013 Mar;20(3):408-18
pubmed: 23059786
J Biol Chem. 2004 Sep 10;279(37):38458-65
pubmed: 15247232
Nat Cell Biol. 2013 May;15(5):533-43
pubmed: 23624405
Leukemia. 2015 Dec;29(12):2366-74
pubmed: 26104662
FASEB J. 2003 Feb;17(2):271-3
pubmed: 12490539
Hypoxia (Auckl). 2016 Apr 11;4:53-67
pubmed: 27800508
Science. 2001 Apr 20;292(5516):464-8
pubmed: 11292862
Cell Stem Cell. 2010 Sep 3;7(3):380-90
pubmed: 20804973
Mol Cell Biol. 2006 Nov;26(22):8336-46
pubmed: 16966370
Cell Stem Cell. 2013 Nov 7;13(5):549-63
pubmed: 24095676
Cancer Lett. 2017 May 1;393:113-124
pubmed: 28153790
Circulation. 2016 Jun 14;133(24):2447-58
pubmed: 27143681
Thromb Haemost. 2018 Feb 07;:
pubmed: 29415284
Stem Cells. 2007 Aug;25(8):1954-65
pubmed: 17478585
J Cell Sci. 2003 Apr 1;116(Pt 7):1319-26
pubmed: 12615973
J Exp Med. 2015 Dec 14;212(13):2223-34
pubmed: 26642852
Carcinogenesis. 2008 Oct;29(10):1853-61
pubmed: 18339685
Blood. 2015 May 21;125(21):3263-72
pubmed: 25855602
Cell. 2015 Nov 19;163(5):1288-1288.e1
pubmed: 26590427
Science. 2001 Nov 9;294(5545):1337-40
pubmed: 11598268
Leukemia. 2015 Jun;29(6):1366-78
pubmed: 25578474
FASEB J. 2019 Feb;33(2):1758-1770
pubmed: 30156910
Nature. 2015 Feb 26;518(7540):542-6
pubmed: 25686605
Nat Genet. 2008 Feb;40(2):170-80
pubmed: 18176562
Cell Stem Cell. 2013 Jan 3;12(1):49-61
pubmed: 23290136
Blood. 2013 Sep 5;122(10):1741-5
pubmed: 23894152
Nat Cell Biol. 2017 Mar;19(3):214-223
pubmed: 28218906
Blood. 2016 Jun 9;127(23):2841-6
pubmed: 27060169
Science. 2001 Apr 20;292(5516):468-72
pubmed: 11292861
Blood. 2011 Jun 9;117(23):e207-17
pubmed: 21447827
Nat Rev Immunol. 2010 Mar;10(3):201-9
pubmed: 20182459
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18154-9
pubmed: 17114296
Mol Cell Biol. 2015 Nov 16;36(3):376-93
pubmed: 26572826
Blood. 2013 Jun 27;121(26):5158-66
pubmed: 23667053
Nature. 2016 Apr 21;532(7599):323-8
pubmed: 27074509
Mol Cell Biol. 1992 Dec;12(12):5447-54
pubmed: 1448077
Leuk Res. 2011 May;35(5):579-84
pubmed: 21176961
J Neurosci. 2006 Sep 13;26(37):9471-81
pubmed: 16971531
Nat Med. 2014 Nov;20(11):1321-6
pubmed: 25326798
Blood. 2013 Feb 21;121(8):1436-45
pubmed: 23264599
Cell Stem Cell. 2009 Mar 6;4(3):263-74
pubmed: 19265665
Cancer Res. 2011 May 1;71(9):3306-16
pubmed: 21436457
Langenbecks Arch Surg. 2012 Dec;397(8):1313-22
pubmed: 22961008
Nature. 2018 Jan 11;553(7687):212-216
pubmed: 29323290
Cell Stem Cell. 2011 Apr 8;8(4):399-411
pubmed: 21474104
J Cell Physiol. 2010 Jan;222(1):17-22
pubmed: 19725055
Cell Rep. 2015 Aug 11;12(6):992-1005
pubmed: 26235614
Leukemia. 2015 Oct;29(10):2075-85
pubmed: 25921247
Wiley Interdiscip Rev Syst Biol Med. 2010 Nov-Dec;2(6):640-53
pubmed: 20890962
Blood. 2014 Dec 4;124(24):3597-607
pubmed: 25267197
Nature. 2012 Jan 25;481(7382):457-62
pubmed: 22281595
Cell Stem Cell. 2011 Oct 4;9(4):298-310
pubmed: 21982230
Blood. 2016 Aug 25;128(8):e20-31
pubmed: 27365425
EMBO Rep. 2019 Jan;20(1):
pubmed: 30429208
J Exp Med. 2011 Feb 14;208(2):261-71
pubmed: 21282381
Nat Med. 2012 Nov;18(11):1651-7
pubmed: 23086476
Immunity. 2006 Dec;25(6):977-88
pubmed: 17174120
Blood. 2008 Mar 15;111(6):3236-44
pubmed: 18096761

Auteurs

Ben Wielockx (B)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, Germany. Ben.Wielockx@tu-dresden.de.

Tatyana Grinenko (T)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, Germany. tatyana.Grinenko@ukdd.de.

Peter Mirtschink (P)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, Germany. Peter.Mirtschink@ukdd.de.

Triantafyllos Chavakis (T)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, 01307 Dresden, Germany. Triantafyllos.chavakis@ukdd.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH